Cancer in children and adolescents in Europe: Developments over 20 years and future challenges


      This special issue contains 18 articles describing population-based analyses of incidence and survival for cancer among children and adolescents in Europe over the period 1978–1997. The analyses were derived from the large database of the ACCIS project (Automated Childhood Cancer Information System), which was built through collaboration of 62 population-based cancer registries in 19 European countries. Data on 88,465 cancers in children and 15,369 in adolescents (age 15–19 yrs) were included in the various analyses, making this the largest database on cancer in these age-groups in the world. National data were grouped into five European regions to allow comparisons of incidence and survival, for all cancers and by tumour type, including analysis of trends in both over time. This overview paper focuses on the comparability of the data from multiple registries and describes the potential confounding factors. Age-standardised annual incidence rates of many, but not all, cancers in children and adolescents are clearly rising. There are geographical differences in survival for the majority of tumour types. Survival rates increased for nearly all types of cancer in children and adolescents. The implications of these findings for aetiological factors and treatment delivery for cancer in children and adolescents are discussed.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Steliarova-Foucher E.
        • Stiller C.
        • Kaatsch P.
        • et al.
        Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since 1970s: the ACCIS project.
        Lancet. 2004; 364: 2097-2105
      1. Parkin DM, Stiller CA, Draper GJ, Bieber CA, Terracini B, Young JL, editors. International incidence of childhood cancer. IARC Scientific Publication No. 87. Lyon: International Agency for Research on Cancer; 1988.

      2. Parkin DM, Kramárová E, Draper GJ, et al. (editors). International incidence of childhood cancer: Vol. 2. IARC Scientific Publication No. 144. Lyon: IARC; 1998.

      3. Capocaccia R, Gatta G, Magnani C, Stiller C, Coebergh J-W, editors. Childhood cancer survival in Europe 1978–1992: the EUROCARE study. Eur J Cancer 2001, 37, 671–816.

        • Gatta G.
        • Corazziari I.
        • Magnani C.
        • Peris-Bonet R.
        • Roazzi P.
        • Stiller C.
        The EUROCARE Working Group Childhood cancer survival in Europe.
        Ann Oncol. 2003; 14: 119-127
        • Kramárová E.
        • Stiller C.A.
        International classification of childhood cancer 1996.
        Int J Cancer. 1996;
      4. Parkin DM, Tyczynski JE, Démaret E, editors. Standards and guidelines for cancer registration in Europe. IARC Technical Publication No. 40, 2003: 69–73.

      5. Fritz A. Percy C. Jack A. International classification of diseases for oncology. 3rd ed. World Health Organization, Geneva2000
      6. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer. 3rd ed. Cancer 2005, 103, 1457–67.

        • Kroll M.E.
        • Draper G.J.
        • Stiller C.A.
        • Murphy M.F.G.
        Childhood leukemia incidence in Britain, 1974–2000: Time trends and possible relation to influenza epidemics.
        J Natl Cancer Inst. 2006; 98: 417-420
        • van der Horst M.
        • Falck Winther J.
        • Olsen J.H.
        Cancer incidence in the age range 0–34 years: Historical and actual status in Denmark.
        Int J Cancer. 2006; 118: 2816-2826
        • Johannesen T.B.
        • Angell-Andersen E.
        • Tretli S.
        • Langmark F.
        • Lote K.
        Trends in incidence of brain and central nervous system tumors in Norway, 1970–1999.
        Neuroepidemiology. 2004; 23: 101-109
        • Agha M.
        • DiMonte B.
        • Greenberg M.
        • Greenberg C.
        • Barr R.
        • McLaughlin J.R.
        Incidence trends and projections for childhood cancer in Ontario.
        Int J Cancer. 2006; 118: 2809-2815
        • Greaves M.
        Infection, immune responses and the aetiology of childhood leukaemia.
        Nat Rev Cancer. 2006; 6: 193-203
        • Terracini B.
        • Coebergh J.-W.
        • Gatta G.
        • et al.
        Childhood cancer survival in Europe: an overview.
        Eur J Cancer. 2001; 37: 810-816
        • Levi F.
        • La Vecchia C.
        • Negri E.
        • Lucchini F.
        Childhood cancer mortality in Europe, 1955–1995.
        Eur J Cancer. 2001; 37 (Erratum in: Eur J Cancer 2001, 37, 2289. Eur J Cancer 2001;37:1727): 785-809
      7. Ramanujachar R, Richards S, Hann I, Webb D. Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols. Pediatr Blood Cancer 2006 (in press). Available online: 8 February 2006.

        • Brenner H.
        Up-to-date survival curves of children with cancer by period analysis.
        Br J Cancer. 2003; 88: 1693-1697
        • Bullard J.
        • Coleman M.P.
        • Robinson D.
        • Lutz J.-M.
        • Bell J.
        • Peto J.
        Completeness of cancer registration: a new method for routine use.
        British Journal of Cancer. 2000; 82: 1111-1116
      8. Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995. The protection of individuals with regard to processing of personal data and on the free movement of such data. Official Journal of the European Communities 1995;281:31–50.